December 14, 2024 10:31 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pushpa 2 stampede: Allu Arjun walks out of jail, actor's lawyer slams delay in release | Donald Trump intends to end 'inconvenient' and 'very costly' Daylight Saving Time | Suchir Balaji: Indian-origin former OpenAI researcher found dead at US apartment | Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days

Eurofins Scientific to acquire Advinus Therapeutics, announces Tata Sons

| | Jul 21, 2017, at 04:11 am
Mumbai/ Kolkata, July 20 (IBNS): Tata Sons, Tata Industries and Rallis India on Thursday announced that they, along with individual shareholders of Advinus Therapeutics (“Advinus”), have signed a definitive agreement with Eurofins Scientific (“Eurofins”) for Eurofins to acquire Advinus.

The transaction is expected to close in the next several weeks, subject to the fulfilment of customary closing conditions. Advinus’ expertise complements Eurofins contract research, development and manufacturing (CDMO) capabilities.

Advinus is a leading preclinical contract research company for Safety Assessment, CMC Services, DMPK and Analytical R&D Services.

With over 10 years of GLP compliance and certification, Advinus serves diverse industries such as Biotech, Pharmaceuticals, Biologics, Agrochemicals, Nutraceuticals and Cosmetics.

Advinus has submitted over 50 end-to-end investigational new drug applications (INDs) to global regulators such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Medicines and Healthcare products Regulatory Agency in the UK (MHRA) and Health Canada among others. Located in Bangalore, India, Advinus operates a state-of-the art 20,000 m2 facility.

KRS Jamwal, Chairman of Advinus and Executive Director of Tata Industries, said: “Advinus has developed significant promise under Tata parenting, and will now realise its full potential joining the Eurofins family of laboratories. We are confident that with access to Eurofins’ global network and technical competencies, Advinus will be able to rapidly expand its analytical portfolio and services to benefit all its existing and future clients.”

Rajiv Malik, Chief Executive Officer of Advinus, said: “Advinus has substantial capabilities that are in synergy with Eurofins and provide us with additional opportunities to grow the Company. We are very excited about becoming a part of the Eurofins family.”
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.